(Updated - January 26, 2026 6:03 AM EST)

Oppenheimer analyst Matt Biegler upgraded Relay Therapeutics (NASDAQ: RLAY) from Perform ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE